Paradoxical enhancement of the activity of a bacterial multidrug transporter caused by substitutions of a conserved residue

Journal of Bacteriology

Volumn 180, Issue 11, 1998, Pages 2817-2821

  Klyachko, Katya A ^a   Neyfakh, Alexander A ^a  

^a UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACRIFLAVINE; BACTERIAL ENZYME; CARRIER PROTEIN; ETHIDIUM; MUTANT PROTEIN; NORFLOXACIN; PROLINE; SERINE; THREONINE;

AMINO ACID SEQUENCE; AMINO ACID SUBSTITUTION; ARTICLE; BACILLUS SUBTILIS; BACTERIAL GROWTH; COCULTURE; CONTROLLED STUDY; DIET RESTRICTION; DRUG TRANSPORT; ENZYME ACTIVATION; ENZYME ACTIVITY; MOLECULAR EVOLUTION; NONHUMAN; PRIORITY JOURNAL; PROTEIN CONTENT; PROTEIN DETERMINATION; PROTEIN DOMAIN; STRUCTURE ACTIVITY RELATION;

EID: 0032469004     PISSN: 00219193     EISSN: None     Source Type: Journal    
DOI: 10.1128/jb.180.11.2817-2821.1998     Document Type: Article

References (16)

1. Ahmed, M., C. M. Borsch, S. S. Taylor, N. Vazquez-Laslop, and A. A. Neyfakh. 1994. A protein that activates expression of a multidrug efflux transporter upon binding the transporter substrates. J. Biol. Chem. 269: 28506-28513.
2. Ahmed, M., L. Lyass, P. N. Markham, S. S. Taylor, N. Vazquez-Laslop, and A. A. Neyfakh. 1995. Two highly similar multidrug transporters of Bacillus subtilis whose expression is differentially regulated. J. Bacteriol. 177:3904-3910.
3. Hopp, T. P., K. S. Prickett, V. Price, R. T. Libby, C. J. March, P. Ceretti, D. L. Urdal, and P. J. Conlon. 1988. A short polypeptide marker sequence useful for recombinant protein identification and purification. Bio/Technology 6:1205-1210.
4. Klyachko, K. A., S. Schuldiner, and A. A. Neyfakh. 1997. Mutations affecting substrate specificity of the Bacillus subtilis multidrug transporter Bmr. J. Bacteriol. 179:2189-2193.
5. Neyfakh, A. A. 1997. Natural functions of bacterial multidrug transporters. Trends Microbiol. 5:309-313.
6. Neyfakh, A. A., V. E. Bidnenko, and L. B. Chen. 1991. Efflux-mediated multidrug resistance in Bacillus subtilis: similarities and dissimilarities with the mammalian system. Proc. Natl. Acad. Sci. USA 88:4781-4785.
7. Nikaido, H. 1996. Multidrug efflux pumps of gram-negative bacteria. J. Bacteriol. 178:5853-5859.
8. Paulsen, I. T., M. H. Brown, and R. A. Skurray. 1996. Proton-dependent multidrug efflux systems. Microbiol. Rev. 60:575-608.
9. Schuldiner, S., A. Shirvan, and M. Linial. 1995. Vesicular neurotransmitter transporters: from bacteria to humans. Physiol. Rev. 75:369-392.
10. Sheppard, D. N., S. M. Travis, H. Ishihara, and M. J. Welsh. 1996. Contribution of proline residues in the membrane-spanning domains of cystic fibrosis transmembrane conductance regulator to chloride channel function. J. Biol. Chem. 271:14995-15001.
11. 385 of GLUT1 perturbs the glucose transport function by reducing conformational flexibility. J. Biol. Chem. 269:2982-2986.
12. Tsen, S. D., S. C. Lai, C. P. Pang, J. I. Lee, and T. H. Wilson. 1996. Chemostat selection of an Escherichia coli mutant containing permease with enhanced lactose affinity. Biochem. Biophys. Res. Commun. 224:351-357.
13. van Helvoort, A., A. J. Smith, H. Sprong, I. Fritzsche, A. H. Schinkel, P. Borst, and G. van Meer. 1996. MDR1 P-glycoprotein is a lipid translocase of broad specificity, while MDR3 P-glycoprotein specifically translocates phosphatidylcholine. Cell 87:507-517.
14. Wellner, M., I. Monden, M. M. Mueckler, and K. Keller. 1995. Functional consequences of proline mutations in the putative transmembrane segments 6 and 10 of the glucose transporter GLUT1. Eur. J. Biochem. 227:454-458.
15. Williams, K. A., and C. M. Deber. 1991. Proline residues in transmembrane helices: structural or dynamic role? Biochemistry 30:8919-8923.
16. Woolridge, D. P., N. Vazquez-Laslop, P. N. Markham, M. S. Chevalier, E. W. Gerner, and A. A. Neyfakh 1997. Efflux of the natural polyamine spermidine facilitated by the Bacillus subtilis multidrug transporter Blt. J. Biol. Chem. 272:8864-8866.